Cathay Biotech Inc. (SHA:688065)

Market Cap	36.51B
Revenue (ttm)	3.05B
Net Income (ttm)	520.65M
Shares Out	720.66M
EPS (ttm)	0.89
PE Ratio	56.90
Forward PE	71.35
Dividend	0.40 (0.78%)
Ex-Dividend Date	Jul 24, 2024

Volume	2,665,432
Average Volume	3,116,209
Open	50.50
Previous Close	50.66
Day's Range	50.11 - 51.09
52-Week Range	32.48 - 56.98
Beta	0.66
RSI	46.34
Earnings Date	Aug 14, 2025

About Cathay Biotech

Cathay Biotech Inc., a bio-manufacturing technology company, researches, develops, produces, and sells bio-based materials in China and internationally. It offers biological long-chain diacids comprising sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine. The products are used in various applications, including textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, and other industries. It provides its products under the TERRYL and ECOPENT brands. Cathay Biotech In...

• Industry: Chemicals
• Sector: Materials
• Founded: 2000
• Employees: 1,735
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688065

Financial Performance

In 2024, Cathay Biotech's revenue was 2.96 billion, an increase of 39.91% compared to the previous year's 2.11 billion. Earnings were 488.96 million, an increase of 33.41%.